Testing effectiveness (Phase 2)Study completedNCT03496168
What this trial is testing
Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER
Who this might be right for
Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 13